跳至主要内容
临床试验/NCT06760091
NCT06760091尚未招募不适用

Multicentric Registry Study of Autoimmune Encephalitis

Xuanwu Hospital, Beijing1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2025年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
200
试验地点
1
主要终点
Change in modified Rankin score (mRS) from baseline

研究概览

简要总结

This study aims to establish an autoimmune encephalitis cohort and observe the prognosis of patients with different subtypes and subgroups (e.g. epilepsy subgroup and teratoma subgroup ). Clinical characteristics, biological samples, and imaging data will be collected to discover blood and imaging biomarkers for providing support for the treatment, early warning, and outcome prediction.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Gender and age are not limited;
  • Newly diagnosed autoimmune encephalitis according to at least one of the following three criteria:
  • According to the criteria of Graus et al in 2016, diagnosed as "definite autoimmune limbic encephalitis"
  • According to the criteria of Graus et al in 2016, diagnosed as "possible autoimmune encephalitis" and typical autoantibodies are detected in serum or cerebrospinal fluid
  • According to the criteria of Graus et al in 2021, diagnosed as "possible or definite paraneoplastic neurological syndrome" (excluding peripheral nervous system syndrome)
  • The patient or legal representative voluntarily signed the paper informed consent form.
  • Additional inclusion criteria for patients in the epilepsy subgroup: patients diagnosed with epilepsy secondary to autoimmune encephalitis.

排除标准

  • No additional exclusion criteria

结局指标

主要结局

Change in modified Rankin score (mRS) from baseline

时间窗: 3months, 6 months, 12months, 24months

Change in modified Rankin score (mRS) from baseline at month 1, month 3, month 6(mRS : Minimum Score 0, Maximum score 6, higher scores mean a worse outcome).

次要结局

  • Proportion of Subjects With Occurrence(12 months, 24 months)
  • Change of Clinical Assessment Scale in Autoimmune Encephalitis (CASE) Score from Baseline(3months, 6 months, 12months, 24months)
  • Changes of pathogenic antibody titers from baseline(3months, 6 months, 12months, 24months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Multicentric Cohort of Autoimmune Encephalitis | 临床试验